Abstracts Programme

Saturday, 4 June

RF-RET-100
Physiological vitreous changes may contribute to the pathogenesis
of atrophic and neovascular macular degeneration
B.C.P. Polak, P.J. Ringens, J.G.F. Worst
The Netherlands

RF-RET-101
Expression of high-mobility groups box-1/receptor for advanced
glycation end products/osteopontin/early growth response-1
pathway in proliferative vitreoretinal epiretinal membranes
A.M. Abu El-Asrar¹, K. Geboes^2
1Saudi Arabia, ²Belgium

RF-RET-102
Fixation patterns in microperimetry of patients with treatmentnaive
neovascular age-related macular degeneration
S. Eisenkoelbl, C.G. Kiss, M.R. Munk, P. Roberts, F. Sulzbacher, U.
Schmidt-Erfurth
Austria

RF-RET-103
The importance of optical coherence tomography examination of
normal fellow eyes in neovascular age-related macular degeneration
monitoring clinics
N. Ajith Kumar, A. Calcagni, J.M. Gibson
United Kingdom

RF-RET-104
Clinical and OCT results after a 6–24 month variable-dosing
regimen of intravitreal ranibizumab in macular degeneration
M.A.J. Wagemans, S.G. Uijl
The Netherlands

RF-RET-105
Number of intravitreal injections in 50 patients with wet-type
macular degeneration treated with combined therapy of low-fluence
PDT and intravitreal ranibizumab (Lucentis) injection over a
24-month follow-up period
M.P. Tsimpida¹, I.J. Datseris², D.P. Tsimpidas^2
1United Kingdom, ²Greece

RF-RET-106
Retinal vascular changes following treatment with dexamethasone
intravitreal implant (DEX implant) in patients with macular edema
(ME) secondary to branch or central retinal vein occlusion (RVO)
S. Sadda, R.P. Danis, J. Jiao, X.Y. Li, S.M. Whitcup
United States

RF-RET-107
Design of a 12-month masked Phase IV study that compares the
safety and efficacy of OzurdexR versus ranibizumab in branch
retinal vein occlusion
A. Tufail¹, A. Kampik², F. Bandello³, E. Souied⁴, M. Figueroa⁵,
A. Heywood¹, A. Fulford-Smith^1
1United Kingdom, ²Germany, ³Italy, ⁴France, ⁵Spain

RF-RET-108
Photodynamic therapy for symptomatic circumscribed choroidal
hemangioma: 4 years of follow-up
T. Gregorio, I. Pires, M.L. Cachulo, C. Farinha, J. Figueira,
P. Fonseca, R. Silva
Portugal

RF-RET-109
Combined phacoemulsification and 23-gauge sutureless vitrectomy
for primary rhegmatogenous retinal detachment: long-term
outcome and complications
G.K.Y. Lee, C.W. Tsang, D.S.C. Lam
Hong Kong

RF-RET-110
Safety and efficacy of small incision 25-gauge vitrectomy in uveitic
cases with posterior segment involvement
M. Kotoula, S. Androudi, A. Praidou, C. Symeonidis, E. Tsironi,
P. Brazitikos
Greece

RF-RET-111
Pseudophakic retinal detachment surgery by 23G vitrectomy using
slitlamp and non contact 90D lens
J.A.C. Pournaras, E.H. Bovey
Switzerland

RF-RET-112
Optic pit: review of surgical cases and description of an innovative
therapy approach
A.S. Travassos, I. Regadas, R.v. Velze, M. Alfaiate, E. Silva, R. Silva,
R. Proenca, A. Travassos
Portugal

RF-RET-113
Experiences of blind retinitis pigmentosa patients with electronic
subretinal implants in daily life
G. Hortdorfer, U. Greppmaier, K. Stingl, B. Wilhelm, E. Zrenner
Germany

RF-RET-114
Firework eye injuries
T. Krasnovid, N. Grubnik, V. Aslanova
Ukraine

 08.15 – 09.45
European Society of Ophthalmology Abstracts Programme
FP01    Cataract/Refractive Surgery

Moderator(s):

Jesper Hjortdal, Denmark José Güell, Spain Matteo Piovella, Italy

FP-REF-001
Keratoconus management combining PRK and CXL treatment.
Results in 85 cases with a follow up of up to 2.5 years
T. Bufidis, D. Mikropulos, D. Dereklis, A.G.P. Konstas, M. Psylla,
M.B. Nasr, A. Dudu, S. Mohindra
Greece

FP-REF-002
Laser in situ keratomileusis in combination with a corneal inlay for
the treatment of presbyopia
A.J. Kanellopoulos
Greece

FP-REF-003
Comparison of LASIK outcomes with the femtosecond laser and
mechanical microkeratome in astigmatic patients
I. Guber, L. Magnin, F. Majo
Switzerland

FP-CAT-004
Evaluation of methods to quantify PCO using forward and
backward scatter of light
O. Findl¹, N. Hirnschall¹, A. Crnej², V. Gangwani^3
1Austria, ²Slovenia, ³United Kingdom

FP-CAT-005
Surface characteristics and roughness of different intraocular lenses
D. Tognetto, P. Cecchini, P. Leon, G. Ravalico
Italy

FP-CAT-006
Synchrony dual-optic accommodating IOL: surgical technique
update and clinical results
M. Piovella
Italy

FP-CAT-007
Cataract surgery on patients with small pupil
Z. Biro
Hungary

FP-CAT-008
Pain perception in sequential cataract surgery: comparison between
first and second procedures
R. Ursea, M.T. Feng, M. Zhou, V. Lien, R. Loeb
United States

FP-CAT-009
Minimising major intraoperative complications of
phacoemulsification surgery further – report of no vitrectomy in
1,000 cases
G.D. Hildebrand, H. Chowdhury
United Kingdom

FP-CAT-010
After-cataract surgery on pediatric pseudophakic eyes
N.F. Bobrova, G.M. Dembovetska
Ukraine

FP-COR-012
Intracorneal ring segment implantation using a new device -
calibrated vacuum ring - as a method of different type keratectasias
treatment
H.P. Takhchidi, B.E. Malyugin, S.B. Izmaylova, S.A. Avramenko
Russia

FP-COR-013
Clinical outocmes analysis of a large sample of eyes implanted with
intrastromal corneal ring segments
P. Ferrara, L. Torquetti, G. Ferrara, J. Merayo
Brazil

FP-COR-014
Deep anterior lamellar keratoplasty (DALK) in patients with
advanced keratoconus
J. Stoiber, J. Ruckhofer, O. Seyeddain, G. Grabner
Austria

FP-COR-015
Cosmetic corneal tattooing: evolution of the tecnique and results
A.F. Duarte, A.S. Ferreira, A. Magrico, F. Trincao, A. Amaro,
F. Loureiro
Portugal

FP-COL-016
The adaptive period in orthokeratology
I.V. Deryapa, O.P. Vitovska, N.A. Obuhova
Ukraine

FP-COL-017
Biodegradable collagen matrix subconjunctival implant
(OculusgenR), our experience in pterygium surgery
N. Saenz-Madrazo, M. Polo-Garcia, C. Reinoso Montalvo,
B. Sarmiento Torres, M.J. Alonso Porres
Spain

FP-COL-018
Our results of descemet’s membrane endothelial keratoplasty
O.G. Oganesyan, D. Danilova, R.A. Gundorova, V.V. Neroyev,
M.A. Smetanina
Russia

FP-COL-019
DMEK-S surgery in patients with posterior polymorphous corneal
dystrophy
K. Liehneova, D. Sivekova, M. Vokrojova, M. Netukova, P. Kuchynka,
P. Studeny
Czech Republic

FP-COL-020
Human corneal endothelial progenitor cells: isolation, analysis and
characterisation
D.V. Patel, J. Yoon, J. McGhee, T. Sherwin, C.N.J. McGhee
New Zealand

FP-COR-022
The architecture of the corneal sub-basal nerve plexus in patients
with type 1 diabetes mellitus
S. Misra, J.P. Craig, C.N.J. McGhee, D.V. Patel
New Zealand

FP-COR-023
Anti-VEGF, amniotic membrane transplantation (AMT) and/or
limbal stem cell transplantation (LCAT) improves corneal graft
survival in high risk cases
I. Dekaris, M. Pauk, S. Sobocanec, M. Korolija, N. Draca, N. Gabria
Croatia

FP-COR-024
Epithelial iris cyst treatment with ethanol irrigation
Z. Behrouzi, N. Khazaei, O. Azimaraghi
Islamic Republic of Iran

FP-COR-025
The effect of VekaciaR (unpreserved cyclosporine cationic
emulsion) on severe corneal involvement in patients with vernal
keratoconjunctivitis participating in a randomized, parallel group
controlled, clinical trial
M. Amrane¹, D. Bremond-Gignac¹, A. Leonardi², M. Deniaud¹,
R.R. Buggage¹, C. Baudouin^1
1France, ²Italy

FP-COR-026
Warming efficiency of warm compresses versus BLEPHASTEAMR
in eyelid therapy
H. Pult¹, B.H. Riede-Pult², C. Purslow^1
1United Kingdom, ²Germany

FP-EXT-027
Changes of meibomian fatty acids composition in patients with
meibomian gland dysfunction after hydrocortisone treatment
P.A. Bezdetko, G.S. Kruglova, O.V. Zavoloka, D.O. Zubkova
Ukraine

FP-EXT-028
Secondary dry eye after refractive surgery: early diagnoses and
treatment
Y. Maychuk, E. Jani
Russia

FP-COR-029
Epidemiology of lid-wiper epitheliopathy in contact lens wearers
and non-contact lens wearers
A. Shiraishi, M. Yamaguchi, M. Ogata, Y. Hara, Y. Ohashi
Japan

FP-COR-030
Anti-inflammatory effect of the amniotic membrane
M. Pauk, R. Grzetic, T. Balog, N. Draca, M. Anticic, I. Dekaris
Croatia

Sunday, 5 June

FP-GLA-032
An association of the Arg399Gln XRCC1 and the Ser326Cys OGG1
gene polymorphisms with a risk of open-angle glaucoma in a Polish
population
J.P. Szaflik, M. Cuchra, M. Gacek, K. Przybylowska, A. Kurowska,
A. Kaminska, J. Szaflik, I. Majsterek
Poland

FP-GLA-033
12-year incidence of exfoliation syndrome in the
Reykjavik eye study
A. Arnarsson¹, F. Jonasson¹, T. Sverrisson¹, K. Damji²,
H. Sasaki³, K. Sasaki^3
1Iceland, ²Canada, ³Japan

FP-GLA-034
The efficacy and safety of adding a brinzolamide/timolol maleate
fixed combination to prostaglandin monotherapy
K. Lorenz, K. Rosbach, A. Matt, N. Pfeiffer
Germany

FP-GLA-035
A 28-day active-controlled, Phase 2b study assessing the safety and
ocular hypotensive efficacy of AR-12286 in patients with elevated
intraocular pressure
T. van Haarlem, J. Serle, G.D. Novack, C. Kopczynski, AR-12286
Phase 2b Study Group
United States

FP-GLA-036
Rationale for development of CatioprostR, a stable preservativefree
cationic emulsion of latanoprost intended for treatment of
glaucoma patients with ocular surface disease
P. Daull¹, J.S. Garrigue¹, R. Buggage¹, J. Serle², H. Liang¹,
F. Brignole-Baudouin¹, C. Baudouin^1
1France, ²United States

FP-GLA-037
Level of satisfaction with eye care among glaucoma patients
S.A. Rikov, O.P. Vitovska, S.V. Zbitneva, G.V. Shpak
Ukraine

FP-GLA-038
Diagnostic value of DDLS and OCT in detecting structural damage
in glaucoma in comparison to optic disc photographs
M. Pomorska, M. Misiuk-Hojlo, K. Dembska
Poland

FP-GLA-039
Miniaturized high-intensity focused ultrasound device for the
treatment of glaucoma: a clinical pilot study
F. Aptel, T. Charrel, C. Lafon, J.Y. Chapelon, J.P. Nordmann, P. Denis
France

   10.15 – 11.45
European Society of Ophthalmology Abstracts Programme
FP05   Electrophysiology/Neuro-ophthalmology/Uveitis

FP-UVE-041
Posterior segment manifestations of scleritis: etiology, associated
systemic diseases and therapy
H.T. Rahman, J. Waltuck, S.K. Srivastava, C.S. Bergstrom, S. Yeh
United States

FP-UVE-042
A prospective, randomized trial of Azithromycin versus Sulfadiazine
and Pyrimethamine for the treatment non vision-threatening ocular
toxoplasmosis
K. Balaskas, J. Vaudaux, M. Cavassini, Y. Guex-Crosier
Switzerland

FP-UVE-043
Eye and sarcoidosis - laboratorial, immunologic profile and
ophthalmologic expression
H.S.L. Seuanes, C.R. Ferreira, J.M.R. Ferreira, M. Aguiar, M.M. Grilo
Portugal

FP-UVE-044
Incidence of events common with corticosteroid use among
individuals with noninfectious uveitis
C.T. Solem, Y. Wan, S. Kirbach, M. Botteman, M. Cifaldi
United States

FP-EPH-045
Changes in dak adaptation and retinal electroretinographic function
after 1 year of sustained glycemia reduction in patients with type 1
diabetes
M. Larsen, S. Holfort, I.C. Munch, K. Klemp, E. Hommel, B. Sander,
S. Madsbad, K. Nørgaard
Denmark

FP-NEO-046
Neuro-ophthalmic complications of chikungunya virus infection
during the virus epidemic
A. Mittal, S. Mittal, R. Ramakrishnan, J.R. Bharthi, P.S. Sathe,
J.S. Thind
India

FP-NEO-047
Efficacy and safety results of a 6-month randomized, placebocontrolled
study (RHODOS) of idebenone in patients with Leber’
Hereditary Optic Neuropathy (LHON)
P.F. Chinnery¹, K. Dimitriadis², J. Rouleau³, P. Yu-Wai-Man¹,
S. Heck², A. Atawan¹, S. Chattopadhyay¹, M. Bailie¹, M. Schubert²,
C. Rummey⁴, G. Metz⁴, M. Leinonen⁵, P.G. Griffiths¹,
W.T. Andrews⁴, T. Meier⁴, T. Klopstock^2
1United Kingdom, ²Germany, ³Canada, ⁴Switzerland, ⁵Sweden

FP-NEO-048
Tolosa Hunt syndrome: the spectrum of a disease. Three case
reports
A.C.R. Almeida, M. Picoto, M.S. Patricio, M. Guedes,
A.P. Mendonca, J. Costa
Portugal

FP-NEO-049
Oculomotor nerve palsy in patients with cerebral aneurysms clinical
features, differential diagnosis, MR imaging, cases reports
A.B. Szabo, J. Szabo
Romania

 14.30 – 16.00
European Society of Ophthalmology Abstracts Programme
FP06    Paediatric Ophthalmology and Strabismus/Education

FP-EDU-058
Ophthalmology teaching at undergraduate level
L. Jawaheer, R. Dwivedi, K. Hiew, J. Hu, D. Kirkham, R. Moylan,
T. Quin, B. Silver, C. Sobajo, K. Stanier, S. Tiew, P. Baker
United Kingdom

FP-PED-050
Ocular cystinosis: a keynote for diagnosis of nephropathic cystinosis
in Egyptian children
A.M. Rizk
Egypt

FP-PED-051
Corneal endothelial cell density long-term after ArtisanR aphakia
IOL implantation for crystalline lens subluxation in 2 patients with
Marfan syndrome
M.L. Sminia, M.T.P. Odenthal, L.J.J. Prick, J.M. Cobben,
M.P. Mourits, H.J. Volker- Dieben
The Netherlands

FP-PED-052
Pediatric ICL implantation
T.A.T. Althomali
Saudi Arabia

FP-PED-053
Corneal topographic changes in children with Down’s syndrome
A.F. Duarte, J.S. Ferreira, A. Paixao, M. Martins, J.P. Cunha,
A. Toscano
Portugal

FP-PED-054
Test-retest reliability of computer-assisted plus disease
quantification using ROPtool
D.K. Wallace, U. Ahmad, S.F. Freedman, Z. Zhao
United States

FP-PED-055
Effects of maternal smoking on the development of retinopathy of
prematurity
S. Fernandez Perez, V. Pueyo Royo, I. Gonzalez Viejo,
C. Ferrer Novella, G. de la Mata Perez, M. Idoipe
Spain

FP-PED-056
Recurrence following intravitreal bevacizumab as monotherapy for
retinopathy of prematurity stage 3 plus
H.A. Mintz-Hittner
United States

FP-EDU-057
Bibliometric Trends in Ophthalmology 1997-2009
A.M. Mansour, G. Mollayes, R. Habib, A. Arabi
Lebanon

FP-EDU-059
Partnership between eye care providers and community based
initiative
S.P. Saikia¹, A. Deka¹, S. Kumar¹, V. Surong^2
1India, ²United Kingdom

Monday, 6 June

 08.15 – 09.45 
European Society of Ophthalmology Abstracts Programme
RF02   Cornea/Contact Lenses/External Eye/Glaucoma/
Paediatric Ophthalmology and Strabismus

RF-COR-115
The effect of CyclokatR (Unpreserved 0.1% cyclosporine cationic
Emulsion) on corneal involvement in patients with moderate to
severe dry eye disease participating in a phase III, multicenter,
randomized, controlled, double-masked, clinical trial
R.R. Buggage¹, M. Amrane¹, D. Ismail¹, M.A. Lemp², A. Leonardi³,
C. Baudouin^1
1France, ²United States, ³Italy

RF-COR-116
Regeneration of corneal epithelium after autograft transplantation
at the stem cell deficiency in experiment
Y.N. Ilyina, P.A. Bezditko, O.V. Zavoloka
Ukraine

RF-COR-117
Peculiarities of treatment of corneal diabetic neuropathy
P.A. Bezditko, O.V. Zavoloka, D.O. Zubkova, A.S. Kruglova
Ukraine

RF-COR-118
Our results of non automated Descemet’s stripping endothelial
keratoplasty
O.G. Oganesyan, D. Danilova, R. Gundorova, V.V. Neroyev,
M.A. Smetanina
Russia

RF-PED-119
The effects on the visual system of exposure to illicit drugs in-utero
M. Hrabovsky, U. Zishan, R. McCullough, A.R. Reddy
United Kingdom

RF-PED-120
ROP laser therapy and anti-VEGF therapy in Estonia 2009
K. Eerme, M. Gersman, P. Juri
Estonia

RF-PED-121
Eye changes in children and young patients with thyroid pathology
D. Jarusaitiene, J. Jankauskiene
Lithuania

RF-GLA-122
The cost-effectiveness of laser peripheral iridotomy for the
treatment of anatomic narrow angles
J.R. Ehrlich, M. Shimmyo, N.M. Radcliffe
United States

RF-COR-123
Efficacy and safety of Baerveldt aqueous shunts in glaucoma
secondary to anterior segment irradiation, for uveal melanoma
E. Sharkawi, L. Franscini, J. Oleszczuk, C. Bergin, A. Schalenbourg,
L. Zografos
Switzerland

RF-GLA-124
Visual outcome after trabeculotomy on primary congenital
glaucoma: a long-term study
R.L. Reis, R. Portugal, J. Cotta, R.S. Silva, A. Magalhaes, J. Breda,
F. Falcao-Reis
Portugal

RF-GLA-125
Diagnostic ability of optic nerve head parameters measured by
optical coherence tomography in glaucoma
L. Gil-Arribas, A. Ferreras, P. Calvo, L. Pablo
Spain

RF-GLA-126
Heidelberg retina tomograph in glaucoma case-finding
C. Bergin, J.D. Oleszczuk, D. Rivier, W. Ferrini, Y. Wimmersberger,
F. Achache, E. Sharkawi
Switzerland

 08.15 – 09.45 
European Society of Ophthalmology Abstracts Programme
FP07   Retina 1

FP-RET-060
Small hard drusen and early AMD: associations with physical
activity, obesity and serum lipids in the inter 99 eye study
I.C. Munch, H. Lund-Andersen, B. Sander, A. Linneberg, M. Larsen
Denmark

FP-RET-061
Bevacizumab vs ranibizumab for exudative AMD in a clinical
setting: one year’s study
P. Monaco, E. Cappello, L. Morgante, A. Frattolillo, M. Del Borrello,
F. Sperti, G. Virgili
Italy

FP-RET-062
Intravitreal injection of ranibizumab for AMD: 3 years experience.
What determines the outcome?
I. Marques, P. Fonseca, M.L. Cachulo, I. Pires, R. Silva
Portugal

FP-RET-063
Is there an accepted protocol for administration of Avastin in
patients with neovascular AMD?
P.I. Vassileva, T.G. Hergeldzhieva-Fileva, Y. Kirilova, N.L. Surchev
Bulgaria

FP-RET-064
Intravitreal ranibizumab for age-related macular degeneration:
optical coherence tomography guided retreatment intervals and
their intra- and inter-individual variability
A. Deli, A. Ambresin, I. Mantel
Switzerland

FP-RET-065
Genetic predisposition of known and new genetic loci to response
to intravitreal ranibizumab in age-related macular degeneration
M. Menghini¹, B. Kloeckener-Gruissem¹, D. Barthelmes²,
W. Berger¹, J.C. Fleischhauer¹, S. Labs¹, M. Kurz-Levin¹,
S. Michels¹, F.K.P. Sutter^1
1Switzerland, ²Australia

FP-RET-066
Triple combination therapy for anti-vascular endothelial growth
factor nonresponders in age-related macular degeneration
J. Lee, W.C. Lam
Canada

FP-RET-067
Comparison of central macular thickness (CMT) measurement
between time domain and spectral domain (SD) optical coherence
tomography (OCT) and reproducibility of SD OCT in active
neovascular AMD
A. Ambresin, I. Mantel, A. Deli
Switzerland

FP-RET-068
Comparison of fundus autofluorescence between fundus camera
(Topcon) and confocal scanning laser ophthalmoscope (HRA) in
various pathologies
I. Mantel, A. Ambresin, A. Deli
Switzerland

FP-RET-069
Variability of iron homeostasis genes in age-related macular
degeneration
J. Blasiak, M. Zaras, J.P. Szaflik, J. Szaflik
Poland

 10.15 – 11.45
European Society of Ophthalmology Abstracts Programme
FP08   Retina 2

FP-RET-070
Non-full-thickness macular holes reassessed with spectral domain
optical coherence tomography
J. Michalewski, Z. Michalewska, D. Odrobina, J. Nawrocki
Poland

FP-RET-071
New vital dyes for vitreoretinal surgery: in vitro study of citotoxicity
and apoptosis retinal pigmented cell culture
F.M. Penha¹, M. Marin-Castano², M. Pons², E.B. Rodrigues¹,
E.P.F. Costa¹, M. Maia¹, M.E. Farah^1
1Brazil, ²United States

FP-RET-072
Longterm outcomes of Oxane HD as intraocular tamponade in the
treatment of complicated retinal detachment at a tertiary referral
centre
C. Dinah, P. Sharma, E. Sykakis, D.G. Cottrell, K.P. Stannard
United Kingdom

FP-RET-073
SF6 and two days posturing versus C3F8 and two days posturing for
idiopathic macular hole repair
T. Xirou¹, V. Xirou², A. Kidess¹, P.G. Theodossiadis¹,
M. Apostolopoulos¹, S.A. Kabanarou¹, P. Fotiou¹, E. Feretis¹,
C. Koutsandrea^1
1Greece, ²United Kingdom

FP-RET-074
The V.E.E. study - primary pars plana vitrectomy with 360°
endolaser therapy or encircling band for rhegmatogenous retinal
detachment
C.I. Falkner-Radler, S. Binder
Austria

FP-RET-075
The safety of 23 Gauge vitrectomy compared to 20 Gauge
vitrectomy performed on patients with PVR retinal detachment
T. Josifova, P.B. Henrich
Switzerland

FP-RET-076
Transconjunctival sutureless vitrectomy as compared to standard
vitrectomy for epiretinal membranes: visual outcomes and
complications
S. Axmann, E. Mendrinos, A. Mateo Montoya, C. Pournaras
Switzerland

FP-RET-077
Abstract has been withdrawn.

FP-RET-078
Macular vitreo-retinal interface abnormalities in highly myopic eyes
with posterior staphyloma: 5-years follow-up
G. Ripandelli, T. Rossi, F. Scarinci, M. Stirpe
Italy

FP-RET-079
Intravitreal bevacizumab versus intravitreal triamcinolone in the
prevention of intraoperative bleeding in diabetic vitrectomy; a
randomized clinical trial
A. Ramezani, M. Entezari, B. Safarpour Lima, H. Fateh Moghadam,
M. Yaseri, H. Mohammad Rabie, Z. Rajavi
Islamic Republic of Iran

 16.30 – 18.00
European Society of Ophthalmology Abstracts Programme
FP09   Oculoplastics/Oncology and Pathology

FP-ONC-080
Plaque brachytherapy for iris melanoma and its effect on corneal
endothelium
L. Razzaq, M.J. Jager, J. Zwaan, M. Marinkovic, G.P.M. Luyten,
R.J.W. de Keizer
The Netherlands

FP-ONC-081
Iridocorneal endothelial (ICE) syndrome masquerading as iris
melanoma in 71 cases
C.L. Shields, M.V. Shields, V. Viloria, H. Pearlstein, E.A.T. Say,
J.A. Shields
United States

FP-ONC-082
Super-selective ophthalmic artery chemotherapy for advanced
retinoblastoma
A. Balmer, S. Binaghi, M. Beck-Popovic, M.C. Gaillard, F.L. Munier
Switzerland

FP-ONC-083
Mucoepidermoid carcinoma of the conjunctiva: a
clinicopathological study of 15 cases
A.P. Moulin, N. Besuchet, D. Martinet, L. Zografos
Switzerland

FP-ONC-084
Neuroprotective activity of idebenone in a mouse model of Leber’s
hereditary optic neuropathy (LHON)
F.D.H. Heitz, C. Anklin, N. Guven
Switzerland

FP-OPL-085
Local steroid injection for management of different types of acute
idiopathic orbital inflammation: an 8-year study
A.A. Mohammad
Egypt

FP-OPL-086
Management of ectropion secondary to dermatitis with tacrolimus
and mometasone: a small case series
S. Tarafdar, Z. Ockrim, C. Clarke, K. Crofts
United Kingdom

FP-OPL-087
Functional multispiral computed tomography in ophthalmoplegia
diagnosis in orbital trauma. First results
Y.O. Grusha, I.V. Bodrova, S.S. Danilov, N.A. Chupova, Y.O. Grusha
Russia

 16.30 – 18.00
European Society of Ophthalmology Abstracts Programme
RF03   Cataract and Refractive Surgery/Oculoplastics/
Oncology and Pathology/Neuro-ophthalmology/Uveitis

RF-CAT-127
Subluxated artificial lens with the capsular bag and anterior capsule
phymosis: surgical management (case report)
D.V. Nicula, C.A. Nicula, L.C. Bran
Romania

RF-CAT-128
Management of bilateral aphakia due to congenital cataract
P. Oikonomidis, T. Giannopoulos, N. Ziakas, K. Boboridis,
V.E. Karampatakis
Greece

RF-CAT-129
Optivis™ multifocal progressive diffractive iol: 1 year clinical
outcomes and contrast sensitivity
A. Mocellin
Italy

RF-CAT-130
Capsulorrhexis made simple
A. Bajaj, K. Marwah
India

RF-UVE-131
OCT characteristics of macular oedema in patients with uveitis
P. Cikatricis, L. Tsierkezou, P. Stavrou
United Kingdom

RF-NEO-133
Long-term effects of the carotid reconstructive surgery on ocular
blood flow
V.V. Neroev, T.N. Kiseleva, A.V. Gavrilenko, N.V. Pak, A.V. Kuklin,
I.I. Fomicheva, S.K. Vlasov
Russia

RF-UVE-134
Efficacy of dexamethasone intravitreal implant for the treatment of
uveitis based on patient-reported vision function outcome measures
S. Lightman¹, C. Lowder², R.K. Naik², D. Revicki², J.W. Kowalski²,
A. Rentz², C.S. Foster², R. Belfort³, H. Cui², S.M. Whitcup², M.D. de Smet^4
1United Kingdom, ²United States, ³Brazil, ⁴The Netherlands

RF-OPL-135
Periocular necrotising fascitis: do not discard conservative
treatment yet!
S. Malik, H.S. Ahluwalia, S. Pagliarini, A.J. Ghauri
United Kingdom

RF-OPL-136
Incidence and demographics of childhood ptosis
B.G. Mohney, G.J. Griepentrog
United States

RF-ONC-137
Ophthalmoscopic differentiation of Coats disease from
retinoblastoma
J.A. Shields, C.L. Shields
United States

RF-ONC-138
The treatment of uveal melanoma by accelerated proton beam
L. Desjardins, L. Lumbroso Le Rouic, C. Levy Gabriel, N. Cassoux,
R. Dendale, C. Plancher, B. Asselain
France

RF-ONC-139
Plaque brachytherapy treatment of iris malignant melanoma using
Ruthenium-106
A.K. Arora, M. Tsimpida, J.L. Hungerford
United Kingdom

RF-OPL-140
The most frequent complications of levator muscle resection:
overview of 200 ptosis cases
K.I. Spahiu, G. Kacaniku, G. Hoxha, M. Ismaili

Tuesday, 7 June

 10.15 – 11.45
European Society of Ophthalmology Abstracts Programme
FP10   Retina 3

FP-RET-090
Characterizing microscopic retinal changes in drusen with and
adaptive optics retinal camera
K. Gocho-Nakashima, M. Benchaboune, M. Ullern, E. Vuaillat,
B. Lamory, J.A. Sahel, M. Paques
France

FP-RET-091
NCX 434, a dual acting compound combining nitric oxide (NO)
donation with triamcinolone acetonide, reduces endothelin-1-
induced ocular ischemia/reperfusion changes in rabbit eyes without
altering intraocular pressure
B. Giambene, F. Impagnatiello, C. Lanzi, A. Pini, S. Brambilla,
C. De Nardi, F. Galassi, E. Masini
Italy

FP-RET-092
Intravitreal antibacterial photodynamic therapy in treatment of
experimental endophthalmitis
A.V. Shatskikh, Y.A. Beliy, A.V. Terescenko, M.A. Plakhotniy
Russia

FP-RET-093
Effect of pegaptanib in treatment-naive patients with diabetic
macular edema: a post hoc analysis
J. Figueira¹, J. Cunha-Vaz¹, C. Starita², D. Zhou^3
1Portugal, ²United Kingdom, ³United States

FP-RET-094
The study of intravitreal injections of bevacizumab and
triamcinolone acetonide in diffuse diabetic macular edema
A.K. Ambade, R.A. Ambade, S. Gupta
India

FP-RET-095
Pooled safety analysis in patients with visual impairment due to
diabetic macular edema treated with 0.5 mg ranibizumab in the
RESOLVE and RESTORE trials
G.E. Lang¹, R.O. Schlingemann², F. Bandello³, D. Leclair⁴,
A. Weichselberger^5
1Germany, ²The Netherlands, ³Italy, ⁴United States, ⁵Switzerland

FP-RET-096
‘En face’ analysis of SD-OCT volume data in Type 2 idiopathic
macular telangiectasia
F.B. Sallo¹, D. Pauleikhoff², A.C. Bird¹, T. Peto^1
1United Kingdom, ²Germany

FP-RET-097
Evaluation of ranibizumab treatment concept based on stability and
deterioration of visual acuity in BRAVO and CRUISE patients
H. Gerding¹, I. Pearce², G. Burian¹, S. Pilz^1
1Switzerland, ²United Kingdom

FP-RET-098
Efficacy and safety of combination therapy with dexamethasone
intravitreal implant (DEX implant) plus laser photocoagulation
versus monotherapy with laser for treatment of diffuse diabetic
macular edema (DDME)
B.D. Kuppermann, D. Callanan, S. Gupta, T.A. Ciulla, D.S. Boyer,
C.C. Liu, J. Lou, X.Y. Li, S.M. Whitcup
United States

FP-RET-099
Association between duration of macular edema and clinical
outcomes in patients with branch retinal vein occlusion following
treatment with dexamethasone intravitreal implant
P. Lanzetta¹, J.A. Haller², B.D. Kuppermann², J.W. Kowalski²,
P. Mitchell³, S.M. Whitcup², T.Y. Wong⁴, W.S. Yeh^2
1Italy, ²United States, ³Australia, ⁴Singapore